Clinical Trials Browser

Phase 2 × Recurrence × Bevacizumab × Clear all

NCT05797246 2026-04-14

Bevacizumab in Adults With Recurrent Respiratory Papillomatosis (RRP)

Phase 2 Active not recruiting

DNA Virus Infections, Infections, Neoplasms, Neoplasms by Histologic Type, Neoplasms, Glandular and Epithelial, Papilloma, Pathologic Processes, Recurrence, Respiratory Tract Diseases, Respiratory Tract Infections, Tumor Virus Infections, Virus Diseases, Neoplasms, Squamous Cell, Disease Attributes, Papillomavirus Infections

NCT01356290 2026-02-23

MEMMAT

Phase 2 Recruiting

Ependymoma, Medulloblastoma, Recurrence

NCT07263438 2026-02-13

Phenix

Phase 2 Recruiting

Glioblastoma, Recurrence

NCT07340164 2026-01-14

TROY

Phase 2 Not yet recruiting

Ovarian Neoplasms, Recurrence

NCT04868708 2025-03-04

A Study of AK104（ an Anti-PD-1 and Anti-CTLA-4 Bispecific Antibody) in Recurrent or Metastatic Cervical Cancer

Phase 2 Completed

Diabetes Mellitus, Insulin-Dependent, 12, Uterine Cervical Neoplasms, Recurrence

NCT06801730 2025-01-30

NALIRIBVRG

Phase 2 Recruiting

Glioma, Recurrence

NCT04739670 2024-03-01

BELLA

Phase 2 Unknown

Recurrence, Triple Negative Breast Neoplasms

NCT06041490 2023-09-18

Adjuvant Therapy for High-risk Hepatocellular Carcinoma Post Liver Transplantation

Phase 2 Not yet recruiting

GastrointestinalSarcoma

Carcinoma, Hepatocellular, Recurrence, Osteosarcoma

NCT03713944 2023-03-01

Carboplatin Plus Pemetrexed Plus Atezolizumab Plus Bevacizumab in Chemotherapy and Immunotherapy-naïve Patients With Stage IV Non-squamous Non-small Cell Lung Cancer

Phase 2 Terminated

30 enrolled 28 charts

Carcinoma, Non-Small-Cell Lung, Recurrence

NCT04015739 2022-08-17

BOLD

Phase 2 Unknown

Carcinoma, Ovarian Epithelial, Recurrence

NCT02337491 2020-12-22

Pembrolizumab +/- Bevacizumab for Recurrent GBM

Phase 2 Completed

80 enrolled 13 charts

NCT01967810 2020-02-25

ANG1005 in Patients With Recurrent High-Grade Glioma

Phase 2 Completed

Brain Neoplasms, Glioblastoma, Glioma, Recurrence

NCT01498328 2020-02-17

ReACT

Phase 2 Completed

Brain Neoplasms, Glioblastoma, Neoplasms, Recurrence, Gliosarcoma

NCT01782976 2018-01-19

Ph II Cilengitide Plus Bevacizumab for Recurrent Glioblastoma (GBM)

Phase 2 Withdrawn

Glioblastoma, Recurrence

NCT01031381 2016-08-30

RADBEV

Phase 2 Completed

50 enrolled 7 charts

Fallopian Tube Neoplasms, Neoplasms, Ovarian Neoplasms, Recurrence

NCT02060955 2016-06-06

Randomized Phase 2 Study to Investigate Efficacy of ALECSAT in Patients With GBM Measured Compared to Avastin/Irinotecan

Phase 2 Terminated

Glioblastoma, Recurrence

NCT01113398 2015-12-10

AMG 102 and Avastin for Recurrent Malignant Glioma

Phase 2 Completed

36 enrolled 9 charts

Glioblastoma, Glioma, Recurrence, Gliosarcoma

NCT00271609 2014-04-29

Bevacizumab for Recurrent Malignant Glioma

Phase 2 Completed

88 enrolled 11 charts

Brain Neoplasms, Glioma, Recurrence

NCT00356122 2011-10-17

Docetaxel & Oxaliplatin in Combination With Bevacizumab as First-Line Treatment in Subjects With Non-Small Cell Lung Cancer (NSCLC)

Phase 2 Completed

53 enrolled 14 charts

Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis, Neoplasms, Recurrence

NCT00463203 2011-06-29

Bevacizumab and Irinotecan for Patients With Primary Brain Tumors and Progression After Standard Therapy

Phase 2 Completed

Brain Neoplasms, Ependymoma, Glioma, Recurrence

NCT00095225 2008-01-29

A Study to Evaluate Bevacizumab and Chemotherapy or Tarceva in Treating Recurrent or Refractory NSCLC (Non-Small Cell Lung Cancer)

Phase 2 Completed

Carcinoma, Non-Small-Cell Lung, Neoplasm Recurrence, Local, Recurrence